Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consider If You Will: Proton Pump Inhibitors in Children, Infections, and Precision Medicine.

Pediatrics - 1 Dec 2019

Hummel Brian A, Rieder Michael

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Cytochrome P-450 CYP2C19
Share to Infections
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Proton Pump Inhibitors

Source

Identifiers

PMID: 31699830
DOI: 10.1542/peds.2019-2544

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consider If You Will: Proton Pump Inhibitors in Children, Infections, and Precision Medicine.PMID 31699830Read ↗

[Dosaging of proton pumps inhibitors].Semantic proximity Read ↗

Proton Pump Inhibitors in childrenSemantic proximity Read ↗

Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice.Semantic proximity Read ↗

Effects of Proton Pump Inhibitors on the Small Bowel and Stool MicrobiomesSemantic proximity Read ↗

Appropriateness and Abuse of Antipyretics, Anti-Inflammatory Drugs and Antibiotics in Children and AdultsSemantic proximity Read ↗

Therapeutics: a glimpse of the future.Semantic proximity Read ↗

Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.Semantic proximity Read ↗

Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysisSemantic proximity Read ↗

Benefits and risks of medications: challenges for the 21st century.Semantic proximity Read ↗

Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)Semantic proximity Read ↗

Laying the foundations for personalized medicines.Semantic proximity Read ↗

When good drugs go bad.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.